Enanta Pharmaceuticals
ENTA
#7341
Rank
ยฃ0.33 B
Marketcap
ยฃ11.62
Share price
-3.08%
Change (1 day)
128.69%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2025 (TTM): -ยฃ57.95 Million

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are ยฃ65.32 Million. In 2024 the company made an earning of -ยฃ71.77 Million, an increase over its 2023 earnings that were of -ยฃ94.26 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ57.95 Million-19.25%
2024 -ยฃ71.77 Million-23.87%
2023 -ยฃ94.26 Million4.39%
2022 -ยฃ90.3 Million-4.4%
2021 -ยฃ94.46 Million91.12%
2020 -ยฃ49.43 Million-407.13%
2019 ยฃ16.09 M-78.63%
2018 ยฃ75.31 M117.97%
2017 ยฃ34.55 M-574.65%
2016 -ยฃ7.28 Million-110.83%
2015 ยฃ67.23 M-4.5%
2014 ยฃ70.39 M-638.53%
2013 -ยฃ13.08 Million-137.98%
2012 ยฃ34.41 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
AbbVie
ABBV
ยฃ1.22 B-2,288.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ23.96 B-42,800.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
ยฃ3.30 B-5,980.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ17.08 B-30,534.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ5.94 B-10,688.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ12.14 B-21,741.54%๐Ÿ‡จ๐Ÿ‡ญ Switzerland